SNHG3 and fatty liver disease: The result showed that T0070907 treatment for 8 weeks had no effects on body weight, liver and iWAT weight, and serum FFAs, TG and TC in Snhg3-HKI mice, but improved Snhg3-induced hepatic steatosis in Snhg3-HKI mice (Figure 8A–D and Figure 8—figure supplement 1).